MedPath

Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation

Not Applicable
Terminated
Conditions
Atrial Fibrillation
Interventions
Other: Unipolar Polarity Switch Left
Other: Unipolar Polarity Switch Right
Registration Number
NCT05464537
Lead Sponsor
Kansas City Heart Rhythm Research Foundation
Brief Summary

The technique of intraprocedural electrogram morphology as a measure of lesion effectiveness in an attempt to achieve durable PVI, clearly led to shortened procedural time, radiation exposure, and superiority in outcomes, with the implementation of a reproducible, readily available intraprocedural tool that can be applied universally.

Detailed Description

One initial study reported that unipolar atrial EGM modification was a useful end point for RF energy delivery. They compared 2 groups of patients with paroxysmal AF undergoing PVI facilitated by an electroanatomic mapping system, merged preprocedural LA computed tomographic scan, and a circular mapping catheter.

They were the first to use intraprocedural electrogram morphology as a measure of lesion effectiveness in an attempt to achieve durable PVI. The technique, clearly led to shortened procedural time, radiation exposure, and superiority in outcomes, with the implementation of a reproducible, readily available intraprocedural tool that can be applied universally.

As there is scant data is this area with lack of randomized human trials, planned on building and further validating evidence from Bortone et al in demonstrating that loss of unipolar negative component during PVI can serve a great adjuvant tool for achieving durability of PVI with overall lesser procedural time and no significant increase in adverse events.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • All Patients ≥ 18 years of age
  • Undergoing pulmonary vein isolation for De-Novo Atrial Fibrillation.
Exclusion Criteria
  • Patients unable to give consent
  • Who do not have De-novo AF.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Unipolar Polarity Switch Left and CAI-OPR-LAAP RightUnipolar Polarity Switch Left-
CAI-OPR-LAAP Left and Unipolar Polarity Switch RightUnipolar Polarity Switch Right-
Primary Outcome Measures
NameTimeMethod
Number of patients with Esophageal Injury1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - Esophageal Injury

Number of patients with TIA/CVA1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - transient ischemic attack/Cerebrovascular accident (TIA/CVA)

Number of patients with Pericardial Effusion1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - Pericardial Effusion

Number of patients with pulmonary vein stenosis1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - pulmonary vein stenosis

Esophageal Temp max (existing protocol)1 day

Esophageal temp max (existing protocol)

Efficacy rate of loss of unipolar negative componentProcedure day and 12 month follow-up day

Observe the efficacy rate of loss of unipolar negative component in isolation of the Pulmonary Veins. Loss of unipolar negative component will be assessed during the Radiofrequency ablation procedure. The durability of Pulmonary vein isolation will be assessed at 12 month follow up, if there is recurrence of Atrial fibrillation.

Number of patients with need for open heart surgery1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - need for open heart surgery

Esophageal "Time above threshold"1 day

Esophageal "Time above threshold"

Number of patients with Bleeding/Hematoma1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - Bleeding/Hematoma

Number of patients with phrenic nerve injury1 year

Number of patients with intraprocedural and post procedure adverse events and serious adverse events - phrenic nerve injury

Esophageal "Time to return to baseline"1 day

Esophageal "Time to return to baseline"

Images comparing PURE EP unipolar signals against Claris unipolar signals1 day

Observe if the quality of PURE EP's unipolar signals are acutely and better suited for lesion assessment? This outcome compares mapping images with site of activation to the PURE EP electrogram and compare if they correspond to each other.

Secondary Outcome Measures
NameTimeMethod
Compare 1st pass isolation1 day

Compare 1st pass isolation in the Unipolar polarity switch group to Carto's Ablation Index per Overland Park Regional's Left Atrial Ablation Protocol (CAI-OPR-LAAP)

6-month freedom from AF6 months

6-month freedom from AF

Location of Catheter tip1 day

Location of Catheter tip (LSPV, RSPV, RIPV, LIPV, LAA, Other) (carto image)

Duration of HFA channel compared to Bipolar1 day

Duration of HFA channel compared to Bipolar, Was there both a near and far field component?

Total RF Time1 day

Total RF Time in pulmonary veins with Unipolar polarity switch as endpoint vs. CAI-OPR-LAAP

Discrimination with High Frequency Algorithm as a confirmation tool1 day

In Left Superior Vein, Right Superior Vein, and Right Inferior Vein, validate Near Field and Far Field Discrimination with High Frequency Algorithm as a confirmation tool (Visitag #'s annotated into PURE EP)

Redo's within 1 year1 year

Redo's within 1 year which vein randomized group reconnected

Trial Locations

Locations (2)

Kansas City Heart Rhythm Institute

🇺🇸

Overland Park, Kansas, United States

Overland Park Regional Medical Center

🇺🇸

Overland Park, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath